↓ Skip to main content

Reducing the risk of harm from intravenous potassium: A multi-factorial approach in the haematology setting

Overview of attention for article published in Journal of Oncology Pharmacy Practice, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reducing the risk of harm from intravenous potassium: A multi-factorial approach in the haematology setting
Published in
Journal of Oncology Pharmacy Practice, September 2013
DOI 10.1177/1078155213504443
Pubmed ID
Authors

Michael Barras, Diana Moore, Daniel Pocock, Myles Sweedman, Cathy Wilkinson, Kerry Taylor, James Morton

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
France 1 2%
Unknown 53 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 18%
Student > Doctoral Student 8 15%
Other 5 9%
Student > Ph. D. Student 4 7%
Student > Bachelor 4 7%
Other 15 27%
Unknown 9 16%
Readers by discipline Count As %
Medicine and Dentistry 13 24%
Nursing and Health Professions 10 18%
Pharmacology, Toxicology and Pharmaceutical Science 7 13%
Business, Management and Accounting 2 4%
Engineering 2 4%
Other 8 15%
Unknown 13 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2014.
All research outputs
#16,681,672
of 26,017,215 outputs
Outputs from Journal of Oncology Pharmacy Practice
#653
of 1,552 outputs
Outputs of similar age
#128,485
of 217,626 outputs
Outputs of similar age from Journal of Oncology Pharmacy Practice
#12
of 24 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,552 research outputs from this source. They receive a mean Attention Score of 3.4. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,626 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.